Pardes Biosciences, Inc. (PRDS) Stock Price & Growth Analysis

New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out

Pardes Biosciences, Inc.

PRDS

NASDAQ

135M

Biotechnology

2.18USD

0.02 ( 0.93%)

Pre-market 0.00$

-2.18 (-100.00%)

Market Closed (as of Aug 30, 19:59 EDT)

Relative Strenght

Volume Buzz

322%

Earning Acce

Yes

Dist 52w H.

41%

Overview Chart

Quote Panel

Updated June 18, 2025

1W % 1M % 3M % 1Y %

Key Metrics

Market Cap
135.19M
Shares Outstanding
62.01M
Share in Float
14.06M
Dividende
0

Earning Date
No Data
Price Target
2.18
Average Volume
509687
Beta
0.423296

Range
0.75-3.67
Industry
Biotechnology
Website
https://www.pardesbio.com
Sector
Healthcare

Quote Panel

Updated June 18, 2025

1W % 1M % 3M % 1Y %

Key Metrics

Market Cap
Shares Outstanding
Share in Float
Dividende

Earning Date
No Data
Price Target
Average Volume
Beta

Range
Industry
Website
Sector

Fundamentals

1.67x

P/E Ratio

0.00x

P/S Ratio

0.70x

P/B Ratio

0.0

Debt/Equity

0.0%

Net Margin

$-1.3

EPS

How PRDS compares to sector?

P/E Ratio

Fundamentals

Relative Strength

PRDS

Sector

Top 5 RS in Group

Symbol	Company	RS	5-Day Perf.

Relative Strength

PRDS

Sector

Top 5 RS in Group

Symbol	Company	RS	5-Day Perf.

Forecast

No Data Available

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Hold

Price Target

NaN(-100.00%)

Number of analyst

Last analyst upgrade/downgrade

JMP Securities

initialise

Previous: Not converted

2022-12-13

Now: Market Outperform

Earnings Growth

YoY

Current

Estimates

Q1.22

N/A

NA
vs -0.08

Q2.22

+434%

0.48
vs -0.14

Q3.22

+297%

0.4
vs -0.20

Q4.22

+209%

0.41
vs -0.38

Q1.23

N/A

0.3
vs NA

Q2.23

-62%

0.18
vs 0.48

Sales Growth

YoY

Current

Estimates

Q1.22

NA vs NA

Q2.22

NA vs NA

Q3.22

NA vs NA

Q4.22

NA vs NA

Q1.23

NA vs NA

Q2.23

NA vs NA

Return on Equity

QoQ

Q3.21

+32%

0.32
vs -1.63

Q4.21

-5%

-0.05
vs 0.32

Q1.22

-9%

-0.09
vs -0.05

Q2.22

-12%

-0.12
vs -0.09

Q3.22

-11%

-0.11
vs -0.12

Q4.22

-28%

-0.28
vs -0.11

Q1.23

-9%

-0.09
vs -0.28

Q2.23

-7%

-0.07
vs -0.09

Institutionnal Ownership

QoQ

Q4.21

41
vs NA

Q1.22

57
vs 41

39%

Q2.22

65
vs 57

14%

Q3.22

63
vs 65

-3%

Q4.22

63
vs 63

Q1.23

59
vs 63

-6%

Q2.23

59
vs 59

Q3.23

1
vs 59

-98%

Earnings Growth

Latest News

accesswire.com

5 hours ago

INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Pardes Biosciences, Inc. and Encourages Investors with Losses to Contact the Firm

accesswire.com

6 hours ago

INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Pardes Biosciences, Inc. and Encourages Investors with Losses to Contact the Firm

accesswire.com

6 hours ago

INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Pardes Biosciences, Inc. and Encourages Investors with Losses to Contact the Firm

globenewswire.com

8 hours ago

Pardes Biosciences Announces Closing of Tender Offer

businesswire.com

11 hours ago

MediPacific Offering $2.13 Per Share Plus One Contingent Value Right Per Share in Tender Offer for Pardes Biosciences

businesswire.com

17 hours ago

MediPacific Announces Calculation of Additional Price Per Share and Extension of Expiration Date for Tender Offer for Pardes Biosciences Shares